Patent · US Active

Method of using PI3K and MEK modulators

US8642584B2 · kind B2 · utility

20Cited by
8References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 7, 2012
Grant dateFeb 4, 2014
Priority date—
Expiry dateAug 7, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods of treating cancer with a combination of compounds which inhibit kinases, more specifically MEK and PI3K.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.